Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NVUS buy 0.99
http://novustherapeutics.com/
https://finance.yahoo.com/quote/NVUS/profile?p=NVUS
https://www.barchart.com/stocks/quotes/NVUS
https://finviz.com/quote.ashx?t=NVUS
https://www.stockconsultant.com/consultnow/basicplus.cgi?symbol=NVUS
https://www.marketscreener.com/quote/stock/NOVUS-THERAPEUTICS-INC-34879319/
normal chart
log chart
normal chart
log chart
* * $NVUS Video Chart 09-15-2020 * *
Link to Video - click here to watch the technical chart video
Huge gains today. Got a order in at .75. I think she’s a good long term investment, but right now she’s all over the place.
Some big names involved in the Preferred stock deal.
* * $NVUS Video Chart 05-14-2020 * *
Link to Video - click here to watch the technical chart video
If you saw this a few weeks ago, you would have known that it was trading below cash just by reading this chart.
NVUS Analysis
* * $NVUS Video Chart 05-13-2020 * *
Link to Video - click here to watch the technical chart video
$.70 lovely
* * $NVUS Video Chart 01-30-2020 * *
Link to Video - click here to watch the technical chart video
* * $NVUS Video Chart 12-10-2019 * *
Link to Video - click here to watch the technical chart video
$NVUS BREAKOUT IMMINENT IN Novus Therapeutics, VOLUME SPIKES
****Alerts are set for a break above the 12ma which has been blocking the stock action for some days, if it can break this level, it's off to the races for some major gains. Volume has spiked today but that it is just for starters, don't miss out on the next big move. ***************
NOVAS THERAPEUTICS INC, DEVELOPS AND SPECIALISES IN DRUGS FOR THE TREATMENT OF EAR, NOSE AND THROAT CONDITIONS.
AVERAGE PRICE TARGET $8.75
AVERAGE ANALYSTS RECOMMENDATION BUY
Been watching it, should have bought it under $2 earlier this year but was too tied up in other positions.
* * $NVUS Video Chart 09-07-18 * *
Link to Video - click here to watch the technical chart video
NVUS News: Withdrawal of Registration Statement (rw) 09/07/2018 09:02 AM
NVUS News: Securities Registration Statement (s-1/a) 09/04/2018 04:40:48 PM
Novus Acquisition and Development, Corp. (OTC PINK: NDEV), through its wholly-owned subsidiary WCIG Insurance Services, Inc., is a diversified insurance entity in health, liability, annuity and accident, and, the nation's first carrier/aggregator offering a cannabis health plan, today announced an agreement with a FinTech technology that will automate and streamline the enrollment process as the insurance industry begins to re-enroll millions of Americans to their health plans.
Reference https://www.morningstar.com/news/access-wire/ASW_Accesswire_510299MSN/novus-signs-agreement-with-cuttingedge-fintech-platform-to-sell-its-novus-cannabis-medplan.html
Novus Acquisition and Development, Corp. (OTC PINK: NDEV), through its wholly-owned subsidiary WCIG Insurance Services, Inc., is a diversified insurance entity in health, liability, annuity and accident, and, the nation's first carrier/aggregator offering a cannabis health plan, today announced an agreement with a FinTech technology that will automate and streamline the enrollment process as the insurance industry begins to re-enroll millions of Americans to their health plans.
Reference https://www.morningstar.com/news/access-wire/ASW_Accesswire_510299MSN/novus-signs-agreement-with-cuttingedge-fintech-platform-to-sell-its-novus-cannabis-medplan.html
still watching.. will wait for a capitulating dip, if at all.
sort of lost interest...
Sure. wish I'd sold $2 higher, but price is now well under the profits I did sell at.
on watch
Sold all in the $6.28 to $6.40 range.. nor reason for this pop other than traders.. maybe keeps going, maybe not. No harm in profits
$NVUS great. A golden cross is the most known bullish technical Parameter
$NVUS Novus Therapeutics Inc (NVUS) Holdings Lifted by Lyon Street Capital LLC https://stocknewstimes.com/2018/04/03/novus-therapeutics-inc-nvus-holdings-increased-by-lyon-street-capital-llc.html
Didn't sell any today. for the length of time I've held, want to see some solid gain on risk. 30% sounds like a good start ;)
let's see what next week brings.
I almost sort of wrote this off many months ago when was trading at lows. luckily other investments still gave me strong port portfolio performance.
this is all free money now.
Will let it ride and maybe I'll get lucky.
TKAI huh... wish I'd sold that one day it shot up to $1.50
lol. thought it was going to go to the moon ;)
6.22 hod. "43.53% of the stock is currently owned by institutional investors and hedge funds". which is pretty high for a #microcap. Company well positioned w/ $19m Cash on Hand. Recent stakes tell me to keep an eye closely. Moves on air..
https://www.dispatchtribunal.com/2018/03/11/ascendiant-capital-markets-initiates-coverage-on-novus-therapeutics-nvus.html/amp?__twitter_impression=true
rule usually to take 1/2 off on going green whenever I've averaged down in price.
basically, take off the extra shares I put on to avg down.
but of course, I got greedy yesterday, which rarely pays.
at least I took 25% off.
Back in the RED today.
deja vu
- luckily this has never been more than 2% of my Port value holdings etc = bagholder quote ;)
@Fairview... all I wanted to do was dump this all day... but this little sob looks like it still has some life in it,,not gonna lie.. I dumped about 25-30%.. I thk I’m regretting it... I SERIOULSY hear echooooos on this blog when I type!! Cobwebs!!!! Hahahah!!!
Yep was down a lot at lows and added once or twice down there...
just took some off here 6.10 - 6.40s (25% of position for couple dollars green.. great investment eh)
I'm just actually following my rule that if I'm going to add and avg down. I have to take "some" off at green or just before.
more times than not, that proves a wise decision. will see
@fairview Same here but looks like it was worth the wait....
Nice. only 5M float. nearing Green. Been holding this for well over a year. The POS that it's been. few K shares with a 6.16 avg.. c'mon go GREEN baby
NVUS is about to run ... I saw on the iHub blog that u were all in awhile go .. So just giving u a heads up!!!
Still Watching. Any Catalysts on Horizon?
Chart Shaping up for reversal. if we can get over $6 and hold could start moving back up.
need some good news and we have a pop
Employee compensation in Shares.. at least they think they are worth something!
IRVINE, California, June 12, 2017 /PRNewswire/ -- Novus Therapeutics, Inc. (NASDAQ: NVUS) announced today that the Compensation Committee of the Company's Board of Directors approved a grant of inducement stock options for two new employees. The Compensation Committee approved a grant of options to purchase 8,700 shares of the Company's common stock with a $4.86 exercise price, the closing price on May 30, 2017. The options have a ten-year term and vest over four years, with one-fourth vesting on the first anniversary of the date of grant and the remaining three-fourths vesting in equal monthly installments thereafter.
The grant was made as an inducement that was a material component of the new employee's compensation and subsequent acceptance of employment with the Company and was granted as an employment inducement award pursuant to Nasdaq Listing Rule 5635(c)(4) approved by the Company's Compensation Committee.
Future Parabolic Runner IMO.. but from where? Well that is the $5,000 question
been adding drips and drabs.. only couple hundred shares at time to add to the few hundred got from TKAI merger
Followers
|
19
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
625
|
Created
|
09/17/14
|
Type
|
Free
|
Moderators |
Novus Therapeutics, Inc., formerly Tokai Pharmaceuticals, Inc., is a pharmaceutical company. The Company is focused on the acquisition, development, and commercialization of ear, nose, and throat products. It has two platforms: OP-01 Foam Platform and OP-02 Surfactant Program. OP-01 is developed with the intent to be used as a delivery vehicle for drugs treating ears, as well as the nasal and sinus cavities. OP-01 is currently being developed as an improved treatment option for acute otitis externa. OP-02 is a daily nasal spray that is designed to improve and maintain a healthy middle ear. OP-02 is being developed as a potential treatment option for patients with otitis media and Eustachian tube dysfunction. OP-02 is a combination drug product, which comprises two components: surfactant dipalmitoylphosphatidylcholine and a spreading agent cholesteryl palmitate. The product is sprayed through the nostrils toward the opening of the Eustachian tube at the back of the nasal cavity.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |